News

Upcoming EFCCA Conference at ECCO Congress 2025 in Berlin

We are excited to invite you to the upcoming EFCCA Conference "What do IBD patients find important in their treatment? -  Results from a global Patient Preference survey” that will take place on 20 February 2025 at the ECCO Congress in Berlin. The conference will focus on the presentation of the EFCCA Survey...

New EFCCA Talk: IUS - Intestinal Ultrasound, a Promising Alternative to Endoscopy?

We are pleased to invite you to our next EFCCA Talk: IUS - Intestinal Ultrasound, a Promising Alternative to Endoscopy? This non-invasive technique is emerging as a valuable tool for diagnosis, treatment, and disease monitoring in IBD patients. During our EFCCA Talk, we will explore: How intestinal ultrasound works and its role in IBD care. Its potential benefits, limitations...

New European Research Project “PerPrev-CID”

New European Research Project “PerPrev-CID” Aiming to revolutionise personalised prevention and early treatment in chronic inflammatory diseases (CIDs), the PerPrev-CID project focuses on advancing risk prediction, early detection of disease progression, and innovative preventive approaches in rheumatoid arthritis (RA) and Inflammatory Bowel Disease (IBD). Chronic inflammatory diseases like...

1st GlycanTrigger Patients Symposium

We are excited to invite you to the 1st GlycanTrigger Patients Symposium, an important event we are co-organising together with the Portuguese Society for Innovation (SPI), focused on collaborative discussions around strategies for predicting and preventing IBD. This virtual symposium will take place on 19 November 2024, from 5:30 PM to 7:00 PM CET via Zoom. This annual event will provide a...

Empowering Patient Voices in Health Technology Assessment: EFCCA's Conference at UEG Week 2024

On 12 October 2024, EFCCA organised a conference during UEG Week in Vienna titled: "How can patients play a crucial role in medicines-related decision-making? An open dialogue with stakeholders and the presentation of the EFCCA HTA Guidebook." EFCCA presented its latest initiative to empower patients in healthcare decision-making: the Guidebook on Health Technology Assessments (HTA). Presented...

EFCCA Magazine 3/2024

New look and new issue of the EFCCA Magazine!  We’re excited to present the latest issue of the EFCCA Magazine, now with a refreshed design! Inside, you’ll find an exclusive interview with Professor James Lee, who shares insights on his groundbreaking research into the causes of Inflammatory Bowel Disease (IBD). In this issue, we also introduce the newly launched EFCCA Youth Group...

Join Our Training Initiatives!

EFCCA is excited to introduce a series of webinars, workshops and initiatives to be launched after the summer break. These sessions are designed to share insights and knowledge from the five Horizon Europe and two H2020 projects in which EFCCA is actively involved and ensure the patient perspective is reflected in the final results.  As a service to our members, these...

Revolutionising IBD Research: James Lee Discusses Landmark Findings

Revolutionising IBD Research: James Lee Discusses Landmark Findings Interviewed by Isabella Haaf  (EFCCA's Head of Communications) In a groundbreaking discovery, UK researchers have identified a new biological pathway that drives Inflammatory Bowel Disease (IBD) and could potentially be targeted with existing drugs. This significant finding  - published in the nature journal - was...

WORLD IBD DAY 2024: Reports on Global Advocacy and IBD Awareness

WORLD IBD DAY 2024: Reports on Global Advocacy and IBD Awareness We are pleased to announce the release of two significant reports that highlight our continuous efforts and achievements in advocating for improved IBD care and quality of life worldwide. World IBD Day 2024 Report This comprehensive document details the inspiring activities and collective efforts from our...

GA 2024 - Brussels

EFCCA General Assembly 2024: A Commitment to Advocacy and Progress   From 7 to 9 June 2024, Brussels hosted the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) General Assembly, representing a significant event for our organisation.                      ...